Commentary: Role of Bone-Modifying Agents in Metastatic Breast Cancer

по Hortobagyi, Gabriel N.
Опубликовано 2011

Toward Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside

по Hortobagyi, Gabriel N.
Опубликовано 2012

Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2()

по Hortobagyi, Gabriel N.
Опубликовано в: Neoplasia (2015)

Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial

по Hortobagyi, Gabriel N.
Опубликовано в: Breast Cancer Res (2018)

Bernard Fisher: A Pioneer Moves On

по Hortobágyi, Gabriel N.
Опубликовано в: Oncologist (2019)

Interpreting Cancer Biology: Refining Our Therapeutic Algorithm in Breast Cancer

по Hortobágyi, Gabriel, Conte, Pierfranco
Опубликовано 2013

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

по Giordano, Sharon H, Hortobagyi, Gabriel N
Опубликовано 2003

Prognostic molecular markers in early breast cancer

по Esteva, Francisco J, Hortobagyi, Gabriel N
Опубликовано 2004

Fingerprinting Lymph Node Metastases

по Symmans, W. Fraser, Hortobagyi, Gabriel N.
Опубликовано 2008

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

по Alvarez, Ricardo H., Hortobagyi, Gabriel N.
Опубликовано 2013

Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long‐Term Dosing

по Hortobagyi, Gabriel N., Zheng, Ming, Mohanlal, Ramon
Опубликовано в: Oncologist (2018)

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

по Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Опубликовано в: Oncotarget (2018)

Hot Flashes: A Review of Pathophysiology and Treatment Modalities

по Morrow, Phuong Khanh H., Mattair, Danielle N., Hortobagyi, Gabriel N.
Опубликовано 2011

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

по Srokowski, Tomasz P., Fang, Shenying, Hortobagyi, Gabriel N., Giordano, Sharon H.
Опубликовано 2009

Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle

по La Vecchia, Carlo, Giordano, Sharon H., Hortobagyi, Gabriel N., Chabner, Bruce
Опубликовано 2011

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validat...

по Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Опубликовано 2003

Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review

по Dawood, Shaheenah, Broglio, Kristine, Buzdar, Aman U., Hortobagyi, Gabriel N., Giordano, Sharon H.
Опубликовано 2010

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

по Bartholomeusz, Chandra, Yamasaki, Fumiyuki, Saso, Hitomi, Kurisu, Kaoru, Hortobagyi, Gabriel N., Ueno, Naoto T.
Опубликовано 2011

Role of Epidermal Growth Factor Receptor in Breast Cancer

по Masuda, Hiroko, Zhang, Dongwei, Bartholomeusz, Chandra, Doihara, Hiroyoshi, Hortobagyi, Gabriel N., Ueno, Naoto T.
Опубликовано 2012

John Mendelsohn: A visionary scientist, oncologist and leader

по Kumar, Rakesh, Murad, Ferid, Bogler, Oliver, O'Malley, Bert W., Hortobagyi, Gabriel N.
Опубликовано в: Genes Cancer (2019)